Literature DB >> 24777468

Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.

Yan Geng1, Jingjing Han, Xuerong Deng, Zhuoli Zhang.   

Abstract

The aim of this study was to evaluate the ultrasonographic synovitis in rheumatoid arthritis (RA) patients who reached clinical remission. Two hundred and two RA patients were enrolled into this study. One hundred and eleven RA patients achieved clinical remission with the treatment of synthetic and/or biologic disease-modifying anti-rheumatic drugs (DMARDs). Subclinical synovitis was assessed by power Doppler ultrasonography (PDUS). PD synovitis was semi-quantitatively recorded. Twenty-two joint regions were imaged: bilateral wrists, metacarpophalangeal (MCP) joints, and proximal interphalangeal (PIP) joints. PD remission was defined as a total PD score of 0. The subclinical synovitis in the RA patients who achieved clinical remission was evaluated. The correlations between PD total scores and clinical/laboratory parameters were analyzed. Among the 111 RA patients who achieved clinical remission, 110 (99.1 %), 67 (60.4 %), 55 (49.5 %), 50 (45.0 %), and 54 (48.6 %) patients, respectively, satisfied DAS28 (CRP), DAS28 (ESR), CDAI, SDAI, and 2010 ACR/EULAR remission criteria. However, only 54 (48.6 %) patients achieved PD remission. Subclinical synovitis was detectable in 57 (51.8 %), 30 (44.8 %), 22 (40.0 %), 19 (38.0 %), and 18 (33.3 %) patients accordingly. On the contrary, 11 (26.8 %) out of 41 patients who fulfilled all five clinical remission criteria had evidence of subclinical synovitis. In those 91 patients who did not achieved clinical remission, total PD score was correlated with swollen joint counts (SJC), tender joint counts (TJC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and complex disease activity indexes (P < 0.01), but not the titers of rheumatoid factor and anti-cyclic citrullinated peptide. Among those 57 patients with subclinical synovitis after reaching clinical remission, no correlation was found between PD total score and SJC, TJC, ESR, CRP, and complex disease activity indexes. Presence of subclinical synovitis is common in patients achieving clinical remission. The stricter clinical remission criteria may reflect less PD synovitis. In patients with active RA, PD total score of synovitis was positively correlated with disease activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777468     DOI: 10.1007/s10067-014-2634-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

2.  Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging.

Authors:  M Szkudlarek; M Court-Payen; C Strandberg; M Klarlund; T Klausen; M Ostergaard
Journal:  Arthritis Rheum       Date:  2001-09

3.  Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity.

Authors:  Violaine Foltz; Frédérique Gandjbakhch; Fabien Etchepare; Carole Rosenberg; Marie Laure Tanguy; Sylvie Rozenberg; Pierre Bourgeois; Bruno Fautrel
Journal:  Arthritis Rheum       Date:  2012-01

4.  Power Doppler ultrasonography and synovitis: correlating ultrasound imaging with histopathological findings and evaluating the performance of ultrasound equipments.

Authors:  J M Koski; S Saarakkala; M Helle; U Hakulinen; J O Heikkinen; H Hermunen
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

5.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Authors:  J S Smolen; F C Breedveld; M H Schiff; J R Kalden; P Emery; G Eberl; P L van Riel; P Tugwell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

6.  Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.

Authors:  Esmeralda T H Molenaar; Alexandre E Voskuyl; Huib J Dinant; P Dick Bezemer; Maarten Boers; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-01

7.  Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria.

Authors:  J Fransen; M C W Creemers; P L C M Van Riel
Journal:  Rheumatology (Oxford)       Date:  2004-07-06       Impact factor: 7.580

8.  American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors:  David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal:  Arthritis Rheum       Date:  2011-03

9.  An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.

Authors:  A K Brown; P G Conaghan; Z Karim; M A Quinn; K Ikeda; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2008-10

10.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maya Buch; Gerd Burmester; Maxime Dougados; Paul Emery; Cécile Gaujoux-Viala; Laure Gossec; Jackie Nam; Sofia Ramiro; Kevin Winthrop; Maarten de Wit; Daniel Aletaha; Neil Betteridge; Johannes W J Bijlsma; Maarten Boers; Frank Buttgereit; Bernard Combe; Maurizio Cutolo; Nemanja Damjanov; Johanna M W Hazes; Marios Kouloumas; Tore K Kvien; Xavier Mariette; Karel Pavelka; Piet L C M van Riel; Andrea Rubbert-Roth; Marieke Scholte-Voshaar; David L Scott; Tuulikki Sokka-Isler; John B Wong; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2013-10-25       Impact factor: 19.103

View more
  8 in total

1.  [Musculoskeletal ultrasound findings of symptomatic joints in patients with systemic lupus erythematosus].

Authors:  Y Geng; B R Li; Z L Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-02-18

2.  The beneficial effect of baricitinib on ultrasound-detected synovial inflammation and bone damage in rheumatoid arthritis: Preliminarily data from single center-based observational study for 24 weeks.

Authors:  Seong-Kyu Kim; Ui Hong Jung; Ji-Won Kim; Jung-Yoon Choe
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

3.  Treat-to-target strategies aiming at additional ultrasound remission is associated with better control of disease activity and less flare in rheumatoid arthritis.

Authors:  Yan Geng; Liujun Wang; Xiaohui Zhang; Lanlan Ji; Xuerong Deng; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2020-06-08       Impact factor: 2.980

4.  Ultrasound-defined remission for good functional status in rheumatoid arthritis.

Authors:  Pinar Kaplan Ozer; Ozlem Sahin; Zafer Ozer; Ahmet Kivanc Cengiz; Yunus Durmaz; Ece Kaptanoglu
Journal:  Indian J Med Res       Date:  2017-08       Impact factor: 2.375

5.  Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data.

Authors:  Svetlana Cherlin; Darren Plant; John C Taylor; Marco Colombo; Athina Spiliopoulou; Evan Tzanis; Ann W Morgan; Michael R Barnes; Paul McKeigue; Jennifer H Barrett; Costantino Pitzalis; Anne Barton; Matura Consortium; Heather J Cordell
Journal:  Genet Epidemiol       Date:  2018-10-12       Impact factor: 2.135

6.  Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis.

Authors:  Coziana Ciurtin; Alexis Jones; Geraint Brown; Fang En Sin; Charles Raine; Jessica Manson; Ian Giles
Journal:  Eur Radiol       Date:  2019-04-26       Impact factor: 5.315

7.  Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Authors:  Elizabeth M A Hensor; Paul McKeigue; Stephanie F Ling; Marco Colombo; Jennifer H Barrett; Jackie L Nam; Jane Freeston; Maya H Buch; Athina Spiliopoulou; Felix Agakov; Stephen Kelly; Myles J Lewis; Suzanne M M Verstappen; Alexander J MacGregor; Sebastien Viatte; Anne Barton; Costantino Pitzalis; Paul Emery; Philip G Conaghan; Ann W Morgan
Journal:  Rheumatology (Oxford)       Date:  2019-03-01       Impact factor: 7.580

8.  Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.

Authors:  Lene Terslev; Cecilie Heegaard Brahe; Mikkel Østergaard; Viktoria Fana; Mads Ammitzbøll-Danielsen; Torsten Møller; Simon Krabbe; Merete Lund Hetland; Uffe Møller Døhn
Journal:  Arthritis Res Ther       Date:  2021-02-01       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.